# OnCo record dem-biopharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/dem-biopharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "dem-biopharma" ;
  schema:name "DEM BioPharma"@en ;
  schema:description "DEM BioPharma develops antibody-drug conjugates, antibodies that carry a cancer-killing drug to tumour cells. Its first medicine, DEM301, is starting an early trial in people with advanced bowel cancer that has spread."@en ;
  schema:url <https://onco.cc/companies/dem-biopharma/>, <https://dembiopharma.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://dembiopharma.com/>, <https://clinicaltrials.gov/study/NCT07805369> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:sections <https://onco.cc/fronts/adcs/>, <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/adc/> .
